Management of Baseline Measurements in Statistical Analysis of 2×2 Crossover Trials
Archives of Advances in Biosciences,
Vol. 10 No. 1 (2019),
12 January 2019
,
Page 13-19
https://doi.org/10.22037/jps.v10i1.16352
Abstract
Introduction: Crossover designs have applications in a wide range of sciences. The simplest and most common of such designs are the two-period, two-treatment (2×2) crossover. As a consequence, each subject provides a 4×1 vector of responses for data analysis in the following chronological order: baseline (period 1), post-baseline (period 1), baseline (period 2), and post-baseline (period 2).Methods: We considered three types of analytic approaches for handling the baselines:1) analysis of variance (ANOVA) method which ignores the first or both period baselines or use a change from baseline analysis 2) analysis of covariance (ANCOVA) method which uses an analysis of covariance where linear functions of one or both baselines are employed as either period-specific or period-invariant covariates 3) Joint modeling method that conducts joint modeling of a linear function of the baseline and post-baseline responses with certain mean constraints for the baseline responses. The crossover clinical trial data was analyzed, using the proposed models. Results: Based on the results on real data among all mentioned models, the first model (direct comparison of post-treatment values) and the second model (post-treatment measurement subtracts corresponding baseline) had the lowest and the highest standard errors, respectively. With respect to Akaike Information Criterion (AIC), the fifth model (comparison of post-treatment values adjusted by all available baseline data) and the eighth model (comparison of post-treatment values adjusted by difference and sum of all available baseline data) had the lowest magnitude, and the ninth model (modeling period baseline jointly with post-treatment values) had the highest AIC for both variables which the values of AIC were 518.1, 520.9 and 1137.8, respectively.Conclusion: To sum up, it is found that baseline data of crossover trial may be used to improve the efficiency of treatment effect estimation when applied appropriately.
- Baseline adjustment
- Covariate
- Crossover trial
- Carryover effect
- Change scores
How to Cite
References
Kenward MG. Crossover Design. Wiley Encyclopedia of Clinical Trials.
Kenward MG, Jones B. The analysis of data from 2× 2 cross‐over trials with baseline measurements. Statistics in Medicine. 1987;6(8):911-26.
Kenward MG, Roger JH. The use of baseline covariates in crossover studies. Biostatistics. 2009:kxp046.
Hills M, Armitage P. The two‐period cross‐over clinical trial. British journal of clinical pharmacology. 2004;58(7):S703-S16.
Wallenstein S, editor Analysis of the crossover design with baseline. American Statistical Association, Proceedings of the Biopharmaceutical Section; 1986.
Willian AR, Pater JL. Using baseline measurements in the two-period crossover clinical trial. Controlled clinical trials. 1986;7(4):282-9.
Metcalfe C. The analysis of cross‐over trials with baseline measurements. Statistics in medicine. 2010;29(30):3211-8.
Chen X, Meng Z, Zhang J. Handling of baseline measurements in the analysis of crossover trials. Statistics in medicine. 2012;31(17):1791-803.
Mehrotra DV. A recommended analysis for 2× 2 crossover trials with baseline measurements. Pharmaceutical statistics. 2014;13(6):376-87.
Patel H. Use of baseline measurements in the two-period crossover design. Communications in Statistics-Theory and Methods. 1983;12(23):2693-712.
Yan Z. The impact of baseline covariates on the efficiency of statistical analyses of crossover designs. Statistics in medicine. 2013;32(6):956-63.
Parham M, Heidari S, Khorramirad A, Hozoori M, Hosseinzadeh F, Bakhtyari L, et al. Effects of pistachio nut supplementation on blood glucose in patients with type 2 diabetes: a randomized crossover trial. Rev Diabet Stud. 2014;11(2):190-6.
Jiang R, Manson JE, Stampfer MJ, Liu S, Willett WC, Hu FB. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA 2002. 288(20):2554-2560.
Lovejoy JC, Most MM, Lefevre M, Greenway FL, Rood JC. Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am J Clin Nutr 2002. 76(5):1000-1006.
- Abstract Viewed: 325 times
- PDF Downloaded: 424 times